CASSS Regional Forum:
Pandemic-paced CMC Development

October 21

Join us for the presentation:
Accelerating process development through outsourcing
Steve Lang, Ph.D., VP Biologics

Schedule a Meeting

What our customers are saying…

…the data they have generated has been used in regulatory filings to enable clinical trials and has informed our clinical indications…
Hector M Rodriguez, PhD, Hector M Rodriguez, previously head of Analytical Biochemistry, Arresto Biosciences. Currently VP of Biology, BridgeBio Pharma

Press Releases


Monopar and NorthStar Partner with Aragen for Testing of Novel Potential Therapeutic for Severe COVID-19


Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate


Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing


COVID-19 update to our customers from Axel Schleyer, CEO


Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia


Aragen Bioscience announces the appointment of Steven Lang, PhD, MBA as Vice President, Biologics